House bill would strengthen federal comparative effectiveness programs

The Christian Science Monitor: "Should the US government mount a comprehensive effort to evaluate the strengths and weaknesses of various treatments for health conditions? That question is at the heart of a dispute over whether some provisions in the healthcare reform bills now under consideration in Congress eventually might lead to the rationing of care.  At issue is comparative effectiveness research, which tries to figure out just how well drugs, medical devices, and surgical techniques work, compared with alternatives. Both the House and current Senate versions of health legislation would expand exisitng federal efforts in this area." 

To supporters, this type of research is a way to try "to increase the efficiency of the bloated US healthcare system. But opponents see it as something that Washington in time might use to restrict patient access to risky, unproven, or expensive treatments."

"Even if the research isn't supported by a possible comprehensive health care overhaul, the stimulus package already includes over $1 billion dollars for it. The reform bill now wending through the House would institutionalize such efforts in a new Center for Comparative Effectiveness Research" (Grier, 8/28).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Heart failure mortality declines in Sweden over two decades